(Q34099102)

31 July 2017

Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial (English)

1 reference

31 July 2017

1 reference

8

M D Ferrari

1 reference

31 July 2017

D J Goldstein

1

1 reference

31 July 2017

K I Roon

2

1 reference

31 July 2017

W W Offen

3

1 reference

31 July 2017

N M Ramadan

4

1 reference

31 July 2017

L A Phebus

5

1 reference

31 July 2017

K W Johnson

6

1 reference

31 July 2017

J M Schaus

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

31 July 2017

1 reference

31 July 2017

358

1 reference

31 July 2017

9289

1 reference

31 July 2017

1230-1234

1 reference

Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Efficacy definitions for migraine studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

1 reference

7 January 2021

How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Cloning and characterization of the guinea pig 5-HT1F receptor subtype: a comparison of the pharmacological profile to the human species homolog

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

Determinants of patient satisfaction with migraine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906347-4

7 January 2021

10.1016/S0140-6736(01)06347-4

Identifiers

DOI

1 reference

31 July 2017

1 reference